In the last trading session, 6.87 million ImmunityBio Inc (NASDAQ:IBRX) shares changed hands as the company’s beta touched 1.15. With the company’s per share price at $5.11 changed hands at -$0.95 or -15.68% during last session, the market valuation stood at $3.44B. IBRX’s last price was a discount, traded about -35.62% off its 52-week high of $6.93. The share price had its 52-week low at $1.25, which suggests the last value was 75.54% up since then. When we look at ImmunityBio Inc’s average trading volume, we note the 3-month average coming to 4.09 million.

ImmunityBio Inc (NASDAQ:IBRX) trade information

Instantly IBRX was in red as seen at the end of in last trading. With action -10.51%, the performance over the past five days has been red. The drop to weekly highs of 6.33 subtracted -15.68% to the stock’s daily price. The company’s shares are showing year-to-date upside of 1.79%, with the 5-day performance at -10.51% in the red. However, in the 30-day time frame, ImmunityBio Inc (NASDAQ:IBRX) is 0.59% up.

ImmunityBio Inc (IBRX) estimates and forecasts

Data shows that the ImmunityBio Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 275.74% over the past 6 months, a 31.31% in annual growth rate that is considerably higher than the industry average of 13.00%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 1.17%. The 2024 estimates are for ImmunityBio Inc earnings to increase by 40.87%, but the outlook for the next 5-year period is at -1.70% per year.